CDK2 and cancer: CXCR2 activation also reduces the expression of p21 and increases the expression of cyclins and cyclin dependent kinases such as cyclin A, cyclin B1, cyclin D1, cyclin E, CDK2, and CDK6, thereby promoting the increased proliferation of cancer cells [52].